Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on June 3, 2025
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
GlobeNewswire
·
June 3, 2025
Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company …
Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa
GlobeNewswire
·
June 3, 2025
ORION OYJ LEHDISTÖTIEDOTE 3.6.2025 klo 23.30 Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa Darolutamidi on ensimmäinen ja ainoa androgeenireseptorin …
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
GlobeNewswire
·
June 3, 2025
ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer Darolutamide is the first and only in the U.S. and FDA-approved androgen receptor inhibitor ( …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 3, 2025
WALTHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
HeartCore Signs 15th Go IPO Contract
GlobeNewswire
·
June 3, 2025
NEW YORK and TOKYO, June 03, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and data consulting services company based in Tokyo, announced that it has signed an agreement (“ …
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
GlobeNewswire
·
June 3, 2025
ROCKVILLE, MD, June 03, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today …
IGEL übernimmt Stratodesk: Mehr Reichweite und mehr Kompetenz im sicheren Endpoint Computing
GlobeNewswire
·
June 3, 2025
FORT LAUDERDALE, Florida, June 03, 2025 (GLOBE NEWSWIRE) -- IGEL, die sichere Endpoint-OS-Plattform für SaaS, DaaS, VDI und sichere Enterprise-Browser, gibt heute die Übernahme von Stratodesk bekannt – einem renommierten Anbieter von Betriebssystem- und …
Innventure to Participate in Upcoming Investor Conferences
GlobeNewswire
·
June 3, 2025
ORLANDO, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV) (“Innventure”), a technology commercialization platform, today announced its participation at the following investor conferences: June 12, 2025 – Lucas Harper, Chief Investment …
Microchip Technology to Present at the Bank of America 2025 Global Technology Conference
GlobeNewswire
·
June 3, 2025
CHANDLER, Ariz., June 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Bank of America 2025 …
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
GlobeNewswire
·
June 3, 2025
KUALA LUMPUR, MALAYSIA, June 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has received …
Fortrea to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
June 3, 2025
DURHAM, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Interim Chief Executive Officer, Peter M. Neupert and Chief Financial Officer, Jill McConnell …
AGM Group Holdings Inc. Announces Completion of 50 for 1 Share Consolidation
GlobeNewswire
·
June 3, 2025
Beijing, June 03, 2025 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, announced …
Brilliant Earth Announces Participation in the 15th Annual East Coast IDEAS Investor Conference
GlobeNewswire
·
June 3, 2025
SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that the Company will participate in the …
SPS Commerce to Present at the 1st Annual D.A. Davidson Technology & Consumer Conference
GlobeNewswire
·
June 3, 2025
MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced that management will present at the 1st Annual D.A. Davidson Technology …
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
GlobeNewswire
·
June 3, 2025
MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the European launch of OviTex Inguinal …
Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
GlobeNewswire
·
June 3, 2025
Best-in-disease profile with JAK-like efficacy and monthly (Q4W) dosing in both three-month placebo-controlled and six-month blinded treatment period Favorable safety and tolerability, particularly when compared to standard of care biologics or JAKs Max …
Windtree Announces Plan for Cryptocurrency Treasury Policy
GlobeNewswire
·
June 3, 2025
WARRINGTON, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 3, 2025
VANCOUVER, British Columbia and BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
Zest Unveils New App-Based Brain Aging Test to Help Prevent Dementia Decades Before Symptoms Begin
EIN Presswire
·
June 3, 2025
Developed in partnership with the University of Cambridge, the 10-minute PREMAZ assessment is now available for free LONDON, GREATER LONDON, UNITED KINGDOM, June 3, 2025 /EINPresswire.com/ -- Zest, a longevity-focused biotech company, has joined forces …
British Army Reservists Successfully Summit Mount Everest
EIN Presswire
·
June 3, 2025
First mixed-gender Army Reserve team reaches the world’s highest peak with Iqarus medical support LONDON, UNITED KINGDOM, June 3, 2025 /EINPresswire.com/ -- A team of eight British Army Reservists from the Honourable Artillery Company (HAC) has made …